Amlodipine Alternatives Compared
Amlodipine | Lisinopril | Losartan |
|
---|
Amlodipine | Lisinopril | Losartan |
|
|||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Amlodipine may be used for the treatment of angina or to lower blood pressure but can cause edema in the feet. Prescribed for Raynaud's Syndrome, High Blood Pressure, Angina, Heart Failure, Coronary... View more |
Lisinopril can be used to treat high blood pressure, heart failure, and to increase survival following a heart attack. However, the development of a dry, hacking cough attributable to the drug may... View more |
Losartan works on a hormone called angiotensin II to lower blood pressure and may also improve kidney function in some people. People being initiated on losartan should be adequately rehydrated and... View more |
Choose a suggestion below High Blood Pressure (Hypertension)
Popular Comparisons
|
|||||||||||||||||||||||
More about Amlodipine | More about Lisinopril | More about Losartan | ||||||||||||||||||||||||
Generic Status | ||||||||||||||||||||||||||
Availability | ||||||||||||||||||||||||||
Prescription only |
Prescription only |
Prescription only |
||||||||||||||||||||||||
Ratings & Reviews | ||||||||||||||||||||||||||
Amlodipine has an average rating of 4.2 out of 10 from a total of 712 ratings on Drugs.com. 26% of reviewers reported a positive effect, while 56% reported a negative effect. |
Lisinopril has an average rating of 5.1 out of 10 from a total of 594 ratings on Drugs.com. 35% of reviewers reported a positive effect, while 43% reported a negative effect. |
Losartan has an average rating of 4.6 out of 10 from a total of 514 ratings on Drugs.com. 27% of reviewers reported a positive effect, while 47% reported a negative effect. |
||||||||||||||||||||||||
Drug Class | ||||||||||||||||||||||||||
Side Effects | ||||||||||||||||||||||||||
Commonly reported side effects include: edema. See the full amlodipine side effects document. |
Commonly reported side effects include: dizziness, hypotension, hyperkalemia, increased blood urea nitrogen, increased serum creatinine. See the full lisinopril side effects document. |
Commonly reported side effects include: asthenia, chest pain, diarrhea, fatigue, hypoglycemia. See the full losartan side effects document. |
||||||||||||||||||||||||
Pricing and Coupons * Prices are without insurance | ||||||||||||||||||||||||||
View all amlodipine prices |
View all lisinopril prices |
View all losartan prices |
||||||||||||||||||||||||
Dosage Form(s) Available | ||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||
Brand Names | ||||||||||||||||||||||||||
Katerzia, Norliqva, Norvasc | Prinivil, Qbrelis, Zestril | Cozaar | ||||||||||||||||||||||||
Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | ||||||||||||||||||||||||||
35 hours |
16.4 hours |
4.4 hours |
||||||||||||||||||||||||
CSA Schedule** View glossary of terms | ||||||||||||||||||||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||||||||||
Pregnancy Category | ||||||||||||||||||||||||||
Category C
Risk cannot be ruled out
See the full Pregnancy Warnings document. |
Category D
Positive evidence of risk
See the full Pregnancy Warnings document. |
Category D
Positive evidence of risk
See the full Pregnancy Warnings document. |
||||||||||||||||||||||||
Drug Interactions | ||||||||||||||||||||||||||
A total of 448 drugs are known to interact with amlodipine:
|
A total of 373 drugs are known to interact with lisinopril:
|
A total of 294 drugs are known to interact with losartan:
|
||||||||||||||||||||||||
Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||||||||||
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
|
|
||||||||||||||||||||||||
Disease Interactions | ||||||||||||||||||||||||||
First Approval Date | ||||||||||||||||||||||||||
July 31, 1992 |
December 29, 1987 |
April 14, 1995 |
||||||||||||||||||||||||
WADA Class View World Anti-Doping Agency classifications. | ||||||||||||||||||||||||||
N/A |
N/A |
N/A |
||||||||||||||||||||||||
More Information | ||||||||||||||||||||||||||
Patient resources | ||||||||||||||||||||||||||
Professional Resources | ||||||||||||||||||||||||||
Related Treatment Guide | ||||||||||||||||||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.